MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$20,412K
(-38.41%↓ Y/Y)
Interest income
$1,514K
(-30.10%↓ Y/Y)
Non-cash royalty income
$854K
(2.52%↑ Y/Y)
Net loss
-$19,824K
(-31.42%↓ Y/Y)
Total other
comprehensive (loss) income
-$588K
(-274.48%↓ Y/Y)
Total other income
$2,368K
(-21.04%↓ Y/Y)
License And Service
$1,459K
Laboratory Research
Revenue
$537K
Loss from operations
-$22,192K
(-22.72%↓ Y/Y)
Unrealized (loss) gain on
marketable securities, net...
-$588K
(-274.48%↓ Y/Y)
Total revenue
$1,996K
(37.18%↑ Y/Y)
Total costs and
expenses
$24,188K
(23.79%↑ Y/Y)
Research and development
$15,657K
(35.16%↑ Y/Y)
General and
administrative
$6,743K
(9.84%↑ Y/Y)
Licensing
$1,393K
(37.92%↑ Y/Y)
Cost of revenue
$395K
(-21.94%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Aclaris Therapeutics, Inc. (ACRS)
Aclaris Therapeutics, Inc. (ACRS)